An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34 + selected autologous peripheral blood stem cell transplant in neuroblastoma

Bone Marrow Transplantation

Volumn 33, Issue 6, 2004, Pages 651-657

  Powell, J L ^a   Bunin, N J ^a,b   Callahan, C ^a   Aplenc, R ^a,b,c   Griffin, G ^d   Grupp, S A ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Autologous peripheral blood stem cell transplant; CD34 selection; EBV; Lymphoproliferative disease; Neuroblastoma

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GANCICLOVIR; IFOSFAMIDE; IMMUNOGLOBULIN; MELPHALAN; RITUXIMAB; THIOTEPA; VINCRISTINE;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD CLOTTING DISORDER; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; CHILD; CLINICAL ARTICLE; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEPATOSPLENOMEGALY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INTERSTITIAL PNEUMONIA; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; PERIODONTITIS; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SEPSIS; SINUSITIS; SORE THROAT; VIRUS INFECTION; VIRUS PNEUMONIA;

ANTIGENS, CD; ANTIGENS, CD34; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; INCIDENCE; LYMPHOPROLIFERATIVE DISORDERS; MALE; NEUROBLASTOMA; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 1842430617     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704402     Document Type: Article

References (40)

1. Leblond V, Sutton L, Dorent R et al. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center. J Clin Oncol 1995; 13: 961-968.
2. Feigel EG. AIDS-associated malignancies: Research perspectives. Biochim Biophys Acta 1999; 1423: C1-C9.
3. Saemundsen AK, Purtilo DT, Sakamoto K et al. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res 1981; 41 (Part 1): 4237-4242.
4. Motohiko O, Gross TG. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. Am J Med Sci 2000; 319: 392-396.
5. Saemundsen AK, Berkel AI, Henle W et al. Epstein-Barr virus carrying lymphoma in a patient with ataxia telangiectasia. Br J Haematol 1981; 282: 425-427.
6. Curtis RE, Travis LB, Rowlings PA et al. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study. Blood 1999; 94: 2208-2216.
7. Shepherd JD, Gascoyne RD, Barnett MJ et al. Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplant 1995; 15: 639-641.
8. Chao NJ, Berry GJ, Advani R et al. Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Transplantation 1993; 55: 1425-1428.
9. Hauke RJ, Greiner TC, Smir BN et al. Epstein Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: Report of two cases. Bone Marrow Transplant 1998; 21: 1271-1274.
10. Yufu Y, Kimura M, Kawano R et al. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease. Bone Marrow Transplant 2000; 26: 1339-1341.
11. Peniket AJ, Perry AR, Williams CD et al. A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 1998; 22: 307-309.
12. Lones MA, Kirov I, Said JW et al. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient. Bone Marrow Transplant 2000; 25: 1021-1024.
13. Heath J, Broxson E, Dole M et al. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue. J Pediatr Hematol Oncol 2002; 24: 160-163.
14. Stainer CJ, Miflin G, Anderson S et al. A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections. J Hematother 1998; 7: 375-383.
15. Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-Cis retinoic acid. N Engl J Med 1999; 341: 1165-1173.
16. Grupp SA, Stern JW, Bunin N et al. Rapid-sequence tandem transplant for children with high-risk neuroblastoma. Med Pediatr Oncol 2000; 35: 696-700.
17. Grupp SA, Stern JW, Bunin N, Nancarrow C. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 2000; 18: 2567-2575.
18. Savoie A, Perpete C, Carpentier L et al. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994; 83: 2715-2722.
19. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997; 15: 405-431.
20. Yao QY, Tierney RJ, Croom-Carter D et al. Frequency of multiple Epstein-Barr virus infections from T cell-immunocompromised individuals. J Virol 1996; 70: 4884-4894.
21. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-492.
22. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997; 15: 405-431.
23. List AF, Greco A, Vogler LB. Lymphoproliferative diseases in immunocompromised hosts; the role of Epstein-Barr virus. J Clin Oncol 1987; 5: 1673-1689.
24. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323: 1767-1769.
25. Martin PJ, Shulman HM, Schubach WH et al. Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T cell antibody. Ann Intern Med 1984; 101: 310-315.
26. Chiang KY, Hazlett LJ, Godder KT et al. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation. Bone Marrow Transplant 2001; 28: 1117-1123.
27. Shapiro R, McClain K, Frizzera G et al. Epstein-Barr virus-associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71: 1234.
28. Briz M, Fores R, Regidor C et al. Epstein-Barr virus associated B cell lymphoma after autologous bone marrow transplantation for T cell acute lymphoblastic leukaemia. Br J Haematol 1997; 98: 485-487.
29. Young L, Alfieri C, Hennessy K et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080-1085.
30. Zutter MM, Martin PJ, Sale GE et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520-529.
31. Faye A, Quartier P, Requerre Y et al. Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children. Br J Haematol 2001; 115: 112-118.
32. Gross TG, Steinbuch M, DeFor T et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: Risk factors, treatment and outcome. Bone Marrow Transplant 1999; 23: 251-258.
33. Garnier JL, Stevenson G, Blanc-Brunat N et al. Treatment of post-transplant lymphomas with anti-B cell monoclonal antibodies. Recent Results Cancer Res 2002; 159: 113-122.
34. Philip T, Landstein R, Zucker JM et al. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 Study. Br J Cancer 1993; 67: 119-127.
35. Meij P, van Esser JWJ, Niesters HGM et al. Impaired recovery of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk of progressive EBV reactivation and lymphoproliferative disease. Blood 2003; 101: 4290-4297.
36. Mackall CL, Fleisher TA, Brown MR et al. Age, thymopoiesis and CD4+ T lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-149.
37. Mackall CL, Stein D, Fleisher TA et al. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood 2000; 98: 754-762.
38. Meijer E, Slaper-Coretenbach ICM, Thijsen SFT et al. Increased incidence of EBV-associated LPD after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique. Bone Marrow Transplant 2002; 29: 325-329.
39. Weinberg K, Blazar BR, Wagner JE et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 2001; 97: 1458-1466.
40. Laport GG, Levine BL, Stadtmauer EA et al. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin's lymphoma following CD34-selected hematopoietic cell transplantation. Blood 2003; 102: 2004-2013.